The many faces of cytokine storm syndrome: immunopathogenic mechanisms and clinical implications for a better patient management
Clicks: 14
ID: 319485
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
3.9
/100
14 views
8 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #11 of 32 articles by views in Clinical & Experimental Immunology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Cytokine storm syndrome is a life-threatening hyperinflammatory condition characterized by excessive and dysregulated immune activation, leading to multiorgan dysfunction and poor clinical outcomes if not promptly recognized and adequately treated. Rather than representing a single disease entity, cytokine storm syndrome is increasingly understood as a final common pathogenic pathway shared by a broad spectrum of clinical conditions converging on overlapping immunopathological mechanisms driven by sustained cytokine production, immune-cell hyperactivation, and failure of immune-regulatory pathways. The clinical presentation of cytokine storm syndrome is characterized by rapidly progressive nature, multisystem involvement, and the diagnostic challenges arising from nonspecific symptoms and overlapping laboratory features. Hyperferritinaemia emerges as a central laboratory hallmark with both diagnostic and potential pathogenic relevance. Therapeutic management of cytokine storm syndrome requires early recognition and is guided by three core principles: supportive care for organ dysfunction, control of underlying triggers, and timely immunomodulatory or immunosuppressive interventions. Overall, cytokine storm syndrome represents a complex and heterogeneous clinical syndrome in which improved mechanistic understanding, biomarker development, and tailored therapeutic strategies are essential to optimize patient outcomes.
| Reference Key |
openalex_W7167053466
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Piero Ruscitti |
| Journal | Clinical & Experimental Immunology |
| Year | 2026 |
| DOI |
10.1093/cei/uxag039
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.